{"abstract":"The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the notice entitled \"International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; Dronabinol (delta-9 tetrahydrocannabinol) and its Stereoisomers; Cannabis, Cannabis Resin, Extracts and Tinctures; Cannabidiol Preparations; and Pharmaceutical Preparations of Cannabis\" that appeared in the Federal Register of March 1, 2019. The Agency is taking this action to allow interested persons additional time to submit comments.","action":"Notice; reopening of the comment period.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2019/08/29/2019-18714.html","cfr_references":[],"citation":"84 FR 45501","comment_url":null,"comments_close_on":"2019-09-30","correction_of":null,"corrections":[],"dates":"FDA is reopening the comment period for the notice published on March 1, 2019 (84 FR 7064). Submit either electronic or written comments by September 30, 2019.","disposition_notes":null,"docket_ids":["Docket No. FDA-2019-N-0767"],"dockets":[{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":17,"comment_start_date":"2019-08-29","updated_at":"2023-02-28T21:04:00.278-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-2019-N-0767-1940","allow_late_comments":null,"id":"FDA-2019-N-0767-1940","comment_end_date":"2019-10-01","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2019-N-0767","title":"International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; Cannabis and cannabis resin; Dronabinol (delta-9-tetrahydrocannabinol); Tetrahydrocannabinol (Isomers of delta-9-tetrahydrocannabinol); Extracts and tinctures of cannabis; Cannabidiol preparations; Pharmaceutical preparations produced eit"}],"document_number":"2019-18714","effective_on":null,"end_page":45502,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2019/08/29/2019-18714.xml","html_url":"https://www.federalregister.gov/documents/2019/08/29/2019-18714/international-drug-scheduling-convention-on-psychotropic-substances-single-convention-on-narcotic","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2019-18714?publication_date=2019-08-29","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2019-08-29/2019-18714/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":7562,"last_updated":"2026-10-23 02:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2019-08-29/pdf/2019-18714.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2019-18714.pdf?1566996325","publication_date":"2019-08-29","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2019/08/29/2019-18714.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":17,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2019-N-0767","supporting_documents_count":0,"docket_id":"FDA-2019-N-0767","document_id":"FDA-2019-N-0767-1940","regulation_id_number":null,"title":"International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; Cannabis and cannabis resin; Dronabinol (delta-9-tetrahydrocannabinol); Tetrahydrocannabinol (Isomers of delta-9-tetrahydrocannabinol); Extracts and tinctures of cannabis; Cannabidiol preparations; Pharmaceutical preparations produced eit","checked_regulationsdotgov_at":"2023-03-01T02:03:59Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":45501,"subtype":null,"title":"International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; Dronabinol (delta-9 tetrahydrocannabinol) and Its Stereoisomers; Cannabis, Cannabis Resin, Extracts and Tinctures; Cannabidiol Preparations; and Pharmaceutical Preparations of Cannabis; Reopening of the Comment Period","toc_doc":"Convention on Psychotropic Substances, etc.; Scheduling Recommendations; Dronabinol (delta9 tetrahydrocannabinol) and its Stereoisomers; Cannabis, Cannabis Resin, Extracts and Tinctures, etc.","toc_subject":"International Drug Scheduling:","topics":[],"type":"Notice","volume":84}